FARMACOCINÉTICA EXPERIMENTAL Y CLÍNICA
Universidad Autónoma de San Luis Potosí
San Luis Potosí, MéxicoPublicacions en col·laboració amb investigadors/es de Universidad Autónoma de San Luis Potosí (5)
2009
-
Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients
Journal of Pharmacy and Pharmacology, Vol. 61, Núm. 6, pp. 759-766
-
Population pharmacokinetics of albendazole in patients with neurocysticercosis
International Journal of Clinical Pharmacology and Therapeutics, Vol. 47, Núm. 11, pp. 679-685
1999
-
Population pharmacokinetics of amikacin in patients with haematological malignancies
Journal of Antimicrobial Chemotherapy, Vol. 44, Núm. 2, pp. 235-242
1998
-
Influence of clinical diagnosis in the population pharmacokinetics of amikacin in intensive care unit patients
Clinical Drug Investigation, Vol. 15, Núm. 5, pp. 435-444
1996
-
Pharmacokinetics of amikacin in intensive care unit patients
Journal of Clinical Pharmacy and Therapeutics, Vol. 21, Núm. 6, pp. 417-421